Delivery Order SPE2DB20D7066-SPE2DB25FC4QL
- Not listed
- The Defense Logistics Agency awarded a $2,435.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) with an ultimate completion date of July 30, 2025. This non-set-aside delivery order was competitively awarded and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $18,875.65 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count) with an ultimate completion date of September 10, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,882.56 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded and completed on August 8, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,461.52 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets in a 30-tablet quantity, with completion scheduled for August 26, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $8,001.71. This is a firm fixed price, non-competitive delivery order executed under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.52 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by August 4, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded a $3,734.63 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Ondansetron ODT 4 mg on July 26, 2025, with completion expected by July 28, 2025. This competitive award, issued under firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $6,100.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4QLDelivery Order
The Defense Logistics Agency awarded a $4,543.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) with a completion date of September 9, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting relationship with DLA for medical supply chain operations supporting military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities through competitively awarded contracts. This delivery order for Ondansetron—a medication commonly used for nausea and vomiting management in medical settings—reflects the contractor's ongoing role as a critical vendor in the federal pharmaceutical procurement landscape, providing essential medications to support Department of Defense healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/8/25 |